普瑞巴林增效治疗难治性强迫症：一项为期16周的病例系列研究。 - Suppr | 超能文献

Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series.

作者信息

Di Nicola Marco, Tedeschi Daniela, Martinotti Giovanni, De Vita Ofelia, Monetta Marisa, Pozzi Gino, Janiri Luigi

出版信息

J Clin Psychopharmacol. 2011 Oct;31(5):675-7. doi: 10.1097/JCP.0b013e31822c29a8.

DOI:10.1097/JCP.0b013e31822c29a8

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series.普瑞巴林增效治疗难治性强迫症：一项为期16周的病例系列研究。

J Clin Psychopharmacol. 2011 Oct;31(5):675-7. doi: 10.1097/JCP.0b013e31822c29a8.

2

Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder.普瑞巴林增效治疗难治性强迫症。

Int Clin Psychopharmacol. 2011 Jul;26(4):221-4. doi: 10.1097/YIC.0b013e3283466657.

3

Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder.加巴喷丁增效治疗氟西汀治疗的强迫症患者。

J Clin Psychiatry. 1998 Sep;59(9):480-1. doi: 10.4088/jcp.v59n0907d.

4

Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.拉莫三嗪增强治疗抵抗性强迫症患者的五羟色胺再摄取抑制剂治疗作用：一项双盲、安慰剂对照研究。

J Psychopharmacol. 2012 Nov;26(11):1456-62. doi: 10.1177/0269881111431751. Epub 2012 Feb 20.

5

Pregabalin in the treatment of benzodiazepine-induced obsessive-compulsive disorder.普瑞巴林治疗苯二氮䓬类药物所致强迫症

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):2000-1. doi: 10.1016/j.pnpbp.2008.08.016. Epub 2008 Aug 28.

6

Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive-compulsive disorder.卡马西平增强氯米帕明治疗难治性强迫症的疗效。

J Clin Psychiatry. 2000 Jul;61(7):528-9. doi: 10.4088/jcp.v61n0712c.

7

Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.普瑞巴林治疗广泛性焦虑障碍的疗效和安全性：一项为期6周的多中心、随机、双盲、安慰剂对照的普瑞巴林与文拉法辛对比研究。

J Clin Psychiatry. 2006 May;67(5):771-82. doi: 10.4088/jcp.v67n0511.

8

Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.

Int Clin Psychopharmacol. 2006 May;21(3):189-91. doi: 10.1097/01.yic.0000199453.54799.cc.

9

A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin.一例疑诊幻肢痛成功应用度洛西汀和普瑞巴林治疗的病例报告。

Gen Hosp Psychiatry. 2010 Mar-Apr;32(2):228.e5-7. doi: 10.1016/j.genhosppsych.2009.05.012. Epub 2009 Jul 3.

10

Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study.奥氮平增效治疗难治性强迫症：一项初步的、单盲、前瞻性研究。

CNS Drugs. 2009 Dec;23(12):1047-55. doi: 10.2165/11530240-000000000-00000.

引用本文的文献

1

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.加拿大焦虑、创伤后应激障碍和强迫症管理临床实践指南。

BMC Psychiatry. 2014;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2.

2

Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting.在西班牙初级保健环境中，对于先前治疗反应不佳的患者，普瑞巴林作为单药治疗或联合治疗对神经性疼痛的疗效。

Clin Drug Investig. 2013 Sep;33(9):633-45. doi: 10.1007/s40261-013-0116-7.

3

The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice.普瑞巴林对“低门控”人类和小鼠感觉运动门控的影响。

Neuropharmacology. 2012 Sep;63(3):480-5. doi: 10.1016/j.neuropharm.2012.04.018. Epub 2012 May 2.